Kaken Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
16.89 | 110.66 | -84.74% | 16.14 | +4.63% |
| P/S |
|
1.88 | 75.01 | -97.49% |
|
|
| P/BV |
|
0.9427 | 70.3 | -98.66% |
|
|
| P/FCF |
|
320.07 | 79.52 | 302.48% |
|
|
| Ev/Ebitda |
|
7.06 | 18.65 | -62.14% |
|
|
| Ev/S |
|
1.23 | 72.39 | -98.3% |
|
|
| Ev/FCF |
|
216.44 | 24.55 | 781.46% |
|
|
| E/P |
|
0.0612 | -0.1123 | -154.51% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
5/10
|
17.45 | -77.27 | -122.58% | 22.74 | -23.28% |
| ROE |
|
5.73 | -9.19 | -162.35% |
|
|
| ROA |
|
4.75 | -9.6 | -149.47% |
|
|
| ROIC |
|
7.92 | 9.09 | -12.89% |
|
|
| ROS |
|
11.14 | -143.83 | -107.75% |
|
|
| ROCE |
|
6.43 | 6.01 | 6.95% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.3063 | -1.04 | -129.41% | 0.2798 | +9.46% |
| Nеt Debt/Ebitda |
|
-3.72 | 12.09 | -130.78% |
|
|
| Debt/Ratio |
|
0.0224 | 0.1394 | -83.91% |
|
|
| Debt/Equity |
|
0.151 | 18.09 | -99.17% |
|
|
| Debt/Net Income |
|
0.4798 | -1.95 | -124.62% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
5.72 | 2.66 | 114.84% | 4.59 | +24.56% |
| Number of years of dividend growth |
|
0 | 1.27 | -100% | ||
| DSI |
|
0.8571 | 0.7328 | 16.98% |
|
|
| Average dividend growth |
|
-6.7 | -49.62 | -86.49% |
|
|
| Average percentage for 5 years |
|
4.59 | 1.91 | 140.05% |
|
|
| Average percentage for payments |
|
53.38 | 33.37 | 59.97% |
|
|
| Difference from average difference in sector |
|
3.06 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-19.26 | 53.88 | -135.75% | ||
| Growth impulse Ebitda in 5 years |
|
-57.07 | 12.48 | -557.29% | ||
| Growth impulse Net Income in 5 years |
|
-58.57 | -8.53 | 586.64% | ||
| Growth impulse FCF in 5 years |
|
-98.38 | -13.75 | 615.49% | ||
| Growth impulse EPS in 5 years |
|
-57.03 | -67.8 | -15.88% |
IP Score
5.24/10
